The effect of anthelmintic treatment during pregnancy on HIV plasma viral load: Results from a randomized, double-blind, placebo-controlled trial in Uganda

Journal of Acquired Immune Deficiency Syndromes

Volumn 60, Issue 3, 2012, Pages 307-313

  Webb, Emily L ^a   Kyosiimire Lugemwa, Jacqueline ^b   Kizito, Dennison ^b   Nkurunziza, Peter ^b   Lule, Swaib ^b   Muhangi, Lawrence ^b   Muwanga, Moses ^c   Kaleebu, Pontiano ^b   Elliott, Alison M ^a,b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^c Entebbe Hospital   (Uganda)

Author keywords

anthelmintic treatment; clinical trial; helminths; HIV; viral load

Indexed keywords

ALBENDAZOLE; PLACEBO; PRAZIQUANTEL;

ADULT; ARTICLE; CLINICAL EVALUATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DELIVERY; DISEASE TRANSMISSION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEALTH STATUS; HELMINTHIASIS; HIV TEST; HOOKWORM INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SOIL; TRICHURIASIS; UGANDA; VIRUS LOAD;

ADULT; ALBENDAZOLE; ANTHELMINTICS; COHORT STUDIES; DOUBLE-BLIND METHOD; FEMALE; HELMINTHIASIS; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PARTURITION; PRAZIQUANTEL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY COMPLICATIONS, PARASITIC; TIME FACTORS; UGANDA; VIRAL LOAD; YOUNG ADULT;

EID: 84864290933     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3182511e42     Document Type: Article

References (38)

1. UNAIDS. AIDS at 30: Nations at the Crossroads. Geneva, Switzerland: World Health Organization; 2011.
2. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. NEJM. 2011;365:493-505.
3. De Cock KM, Fowler MG, Mercier E, et al. Prevention of motherto-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA. 2000;283:1175-1182.
4. World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. 2010. Available at: http://www.who.int/HIV/pub/guidelines/artadultguidelines.pdf. Accessed March 14, 2012.
5. World Health Organization. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. 2010. Available at: http://www.who.int/HIV/pub/mtct/en/arvdrugswomenguidelinesfinal.pdf. Accessed March 14, 2012.
6. UNAIDS. AIDS Epidemic Update. Geneva, Switzerland: World Health Organization; 2009.
7. Brooker S. Estimating the global distribution and disease burden of intestinal nematode infections: adding up the numbers-a review. Int J Parasitol. 2010;40:1137-1144.
8. Fincham JE, Markus MB, Adams VJ. Could control of soil-transmitted helminthic infection influence the HIV/AIDS pandemic. Acta Trop. 2003;86:315-333.
9. Borkow G, Leng Q, Weisman Z, et al. Chronic immune activation associated with intestinal helminth infections results in impaired signal transduction and anergy. J Clin Invest. 2000;106:1053-1060.
10. Brown M, Mawa PA, Joseph S, et al. Treatment of Schistosoma mansoni infection increases helminth-specific type 2 cytokine responses and HIV-1 loads in coinfected Ugandan adults. J Infect Dis. 2005;191:1648-1657.
11. Hosseinipour MC, Napravnik S, Joaki G, et al. HIV and parasitic infection and the effect of treatment among adult outpatients in Malawi. J InfectDis. 2007;195:1278-1282.
12. Lawn SD, Karanja DM, Mwinzia P, et al. The effect of treatment of schistosomiasis on blood plasma HIV-1 RNA concentration in coinfected individuals. AIDS. 2000;14:2437-2443.
13. Brown M, Kizza M, Watera C, et al. Helminth infection is not associated with faster progression of HIV disease in coinfected adults in Uganda. J Infect Dis. 2004;190:1869-1879.
14. Walson JL, Herrin BR, John-Stewart G. Deworming helminth co-infected individuals for delaying HIV disease progression. Cochrane Database Syst Rev. 2009;(3):CD006419.
15. Kallestrup P, Zinyama R, Gomo E, et al. Schistosomiasis and HIV-1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV-1 RNA load. J Infect Dis. 2005;192:1956-1961.
16. Nielsen NO, Simonsen PE, Dalgaard P, et al. Effect of diethylcarbamazine on HIV load, CD4%, and CD4/CD8 ratio in HIV-infected adult Tanzanians with or without lymphatic filariasis: randomized double-blind and placebocontrolled cross-over trial. Am J Trop Med Hyg. 2007;77:507-513.
17. Walson JL, Otieno PA, Mbuchi M, et al. Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial. AIDS. 2008;22:1601-1609.
18. Gallagher M, Malhotra I, Mungai PL, et al. The effects of maternal helminth and malaria infections on mother-to-child HIV transmission. AIDS. 2005;19:1849-1855.
19. Webb EL, Mawa PA, Ndibazza J, et al. Effect of single-dose anthelmintic treatment during pregnancy on an infant's response to immunisation and on susceptibility to infectious diseases in infancy: a randomised, doubleblind, placebo-controlled trial. Lancet. 2011;377:52-62.
20. Elliott AM, Kizza M, Quigley MA, et al. The impact of helminths on the response to immunization and on the incidence of infection and disease in childhood in Uganda: design of a randomized, double-blind, placebocontrolled, factorial trial of deworming interventions delivered in pregnancy and early childhood ISRCTN32849447. Clin Trials. 2007;4:42-57.
21. Woodburn PW, Muhangi L, Hillier S, et al. Risk factors for helminth, malaria, and HIV infection in iregnancy in Entebbe, Uganda. PLoS Negl Trop Dis. 2009;3:e473.
22. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal singledose nevirapine compared with zidovudine for prevention of mother-tochild transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 1999;354:795-802.
23. Katz N, Chaves A, Pellegrino J. A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo. 1972;14:397-400.
24. Friend J. Helminths. In: Collee J, Frase A, Marmion B, et al, eds. Mackie and McCartney Practical Medical Microbiology. Edinburgh, United Kingdom: Churchill Livingstone; 1996.
25. World Health Organization Report of the WHO informal consultation on hookworm infection and anaemia in girls and women. Geneva 1994. Available at: http://whqlibdoc.who.int/hq/1996/WHO-CTD-SIP-96.1.pdf. Accessed March 14, 2012.
26. World Health Organization. Monitoring Helminth Control Programmes. Guidelines for Monitoring the Impact of Control Programmes Aimed at Reducing Morbidity Caused by Soil-Transmitted Helminths and Schistosomes, With Particular Reference to School-Age Children. Geneva, Switzerland:World Health Organization; 1999.
27. Melrose WD, Turner PF, Pisters P, et al. An improved Knott's concentration test for the detection of microfilariae. Trans R Soc Trop Med Hyg. 2000;94:176.
28. Muhangi L, Woodburn P, Omara M, et al. Associations between mildto-moderate anaemia in pregnancy and helminth, malaria and HIV infection in Entebbe, Uganda. Trans R Soc Trop Med Hyg. 2007;101:899-907.
29. Ndibazza J, Muhangi L, Akishule D, et al. Effects of deworming during pregnancy on maternal and perinatal outcomes in Entebbe, Uganda: a randomized controlled trial. Clin Infect Dis. 2010;50:531-540.
30. Modjarrad K, Chamot E, Vermund SH. Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression. AIDS. 2008;22:2179-2185.
31. Knopp S, Rinaldi L, Khamis IS, et al. A single FLOTAC is more sensitive than triplicate Kato-Katz for the diagnosis of low-intensity soil-transmitted helminth infections. Trans R Soc Trop Med Hyg. 2009;103:347-354.
32. Utzinger J, Booth M, N'Goran EK, et al. Relative contribution of dayto-day and intra-specimen variation in faecal egg counts of Schistosoma mansoni before and after treatment with praziquantel. Parasitology. 2001; 122(pt 5):537-544.
33. Lacey E.Mode of action of benzimidazoles. Parasitol Today. 1990;6:112-115.
34. Skinner-Adams TS, Davis TM, Manning LS, et al. The efficacy of benzimidazole drugs against Plasmodium falciparum in vitro. Trans R Soc Trop Med Hyg. 1997;91:580-584.
35. Barnabas RV, Webb EL, Weiss HA, et al. The role of co-infections in HIV epidemic trajectory and positive prevention: a systematic review and meta-analysis. AIDS. 2011;25:1559-1573.
36. Downs JA, Mguta C, Kaatano GM, et al. Urogenital schistosomiasis in women of reproductive age in Tanzania's Lake Victoria region. Am J Trop Med Hyg. 2011;84:364-369.
37. Kjetland EF, Ndhlovu PD, Gomo E, et al. Association between genital schistosomiasis and HIV in rural Zimbabwean women. AIDS. 2006;20:593-600.
38. Gibson LR, Li B, Remold SK. Treating cofactors can reverse the expansion of a primary disease epidemic. BMC Infect Dis. 2010;10:248.